Skip to main content

Table 1 Basic demographics, volumetric data and patient characteristics

From: Biventricular myocardial strain analysis in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) using cardiovascular magnetic resonance feature tracking

  Healthy volunteers ARVC Borderline ARVC pos. family history
n 10 20 30 22
Sex (m/w) 5/5 17/3 19/11 16/6
Age 24.3 ± 3.0 50.7 ± 16.9*,# 41.4 ± 14.5*,# 29.3 ± 11.7
Weight (kg) 66.4 ± 9.4 81.3 ± 17.3 80.7 ± 16.7 80.3 ± 15.7
Height (cm) 176.1 ± 9.1 178.4 ± 8.0 175.6 ± 8.5 179.3 ± 9.0
Body surface area (m 2 ) 1.81 ± 0.17 1.99 ± 0.22 1.96 ± 0.22 1.99 ± 0.22
RVEDVI (ml/m 2 ) 88.1 ± 12.8 124.4 ± 40.4*,$,# 100.4 ± 31.9 93.2 ± 15.0
RVESVI (ml/m 2 ) 36.7 ± 6.4 78.0 ± 39.8**,$,## 53.2 ± 25.0 45.7 ± 10.8
RVEF (%) 58.3 ± 4.8 40.4 ± 10.9**,$$,## 49.2 ± 8.4* 52.6 ± 6.9
LVEDVI (ml/m 2 ) 79.0 ± 8.2 84.3 ± 18.8 89.4 ± 20.6 88.7 ± 13.2
LVESVI (ml/m 2 ) 28.8 ± 4.5 33.5 ± 14.5 37.7 ± 13.3 35.4 ± 7.1
LVEF (%) 63.6 ± 4.2 60.7 ± 9.2 58.2 ± 7.1 61.3 ± 5.2
Task force score 0 5.5 ± 1.4 1.4 ± 0.8 1.5 ± 0.7
WMA (n) 10/0/0/0/0 7/0/1/4/8 23/0/0/4/3 20/0/0/0/2
RVEF > 45/45 > RVEF > 40/RVEF < 40 10/0/0 8/4/8 22/5/3 20/2/0
  1. Abbreviations: RVEDVI Right Ventricular End-diastolic Volume Index, RVESVI Right Ventricular End-systolic Volume Index, RVEF Right Ventricular Ejection Fraction, LVEDVI Left Ventricular End-diastolic Volume Index, LVESVI Left Ventricular End-systolic Volume Index, LVEF Left Ventricular Ejection Fraction WMA Wall Motion Abnormalities.
  2. WMA is graded in the following order: no WMA/Hypokinesia/Akinesia/Dyskinesia/ Aneurysm.
  3. * significant difference compared to healthy volunteers.
  4. $ significant difference compared to borderline ARVC patients.
  5. # significant difference compared to subjects with positive family history for ARVC.
  6. level of significance * p < 0.05; ** p < 0.01; $$ p < 0.01; ## p < 0.01.